The case for aromatase inhibitors use in Oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in Breast Cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate

Human Fertility

Volumn 16, Issue 4, 2013, Pages 235-240

  Fatum, Muhammad ^a   McVeigh, Enda ^a   Child, Tim ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cancer; Cryopreservation; Fertility preservation

Indexed keywords

AROMATASE INHIBITOR; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LETROZOLE; TAMOXIFEN;

BREAST CANCER; CANCER RECURRENCE; CRYOPRESERVATION; ESTROGEN BLOOD LEVEL; FEMALE; FOLLOW UP; GRANULOSA CELL; HUMAN; NONHUMAN; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; REPRODUCTIVE PROCEDURE; REVIEW;

ANIMALS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CRYOPRESERVATION; ESTRADIOL; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MICE; NITRILES; OOCYTES; OVULATION INDUCTION; TISSUE AND ORGAN HARVESTING; TRIAZOLES;

EID: 84890026498     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.3109/14647273.2013.800650     Document Type: Review

References (38)

1. Atay, V.C., Muhcu, M., Cam, M., & Karateke, A. (2006). Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research, 34, 73-76.
2. Aygen, E.M., Guzel, Z., Ozgun, T., Atakul, T., & Sahin, Y. (2007). The use of letrozole for ovulation induction in infertile women with polycystic ovarian syndrome. Erciyes Tip Dergisi, 29, 195-200.
3. Al-Fadhli, R., Sylvestre, C., Buckett, W., Tan, S.L., & Tulandi, T. (2006). A randomized trial of superovulation with two different doses of letrozole. Fertility & Sterility, 85, 161-164.
4. Al-Omari, W.R., Sulaiman, W.R., & Al-Hadithi, N. (2004). Comparisons of two aromatase inhibitors in women with Clomiphene-resistant polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics, 85, 289-291.
5. Azim, A.A., Costantini-Ferrando, M., Lostritto, K., & Oktay, K. (2007). Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. Journal of Clinical Endocrinology and Metabolism, 92, 2197-2200.
6. Azim, A.A., Costantini-Ferrando, M., & Oktay, K, (2008). Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. Journal of Clinical Oncology, 26, 2630-2635.
7. Badawy, A., Abdel Aal, I., & Abulatta, M. (2009). Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertility & Sterility, 92, 849-852.
8. Bayar, U., Basaran, M., Kiran, S., Coskun, A., & Gezer, S. (2006). Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertility & Sterility, 86, 1447-1451.
9. Biljan, M.M., Hemmings, R., & Brassard, N. (2005). The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertility & Sterility, 84, S95.
10. Bontenbal, M., van Putten, W.L., Burghouts, J.T., Baggen, M.G., Ras, G.J., Stiegelis, W.F., Beudeker, M., Janssen, J.T., Braun, J.J., van der Linden, G.H., van der Velden, P.C., van Geel, A.N., Helle, P., Leisink, M., Foekens, J.A., Klijn, J.G. (2000). Value of estrogenic recruitment before chemotherapy: first randomized trial in primary breast cancer. Journal of Clinical Oncology, 18, 734-742.
11. Brodie, A., Sabnis, G., & Jelova, D. (2006). Aromatase and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology, 102, 97-102.
12. Casper, R.F. & Mitwally, M.F. (2006). Aromatase inhibitors for ovulation induction. The Journal of Clinical Endocrinology & Metabolism, 91, 760-771.
13. Dehbashi, S., Dehbashi, S., Kazerooni, T., Robati, M., Alborzi, S., Parsanezhad, M.E., & Shadman, A. (2009).Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome. Iranian Journal of Medical Sciences, 34, 23-28.
14. Fabian, C.J., Kimler, B.F., McKittrick, R., Park, C.H., Lin, F., Krishnan, L., Jewell, W.R., Osborne, C.K., Martino, S., Hutchins, L.F., Leong, L.A., & Green, S. (1994). Recruitment with high physiological doses of estradiol preceding chemotherapy: flow cytometric and therapeutic results in women with locally advanced breast cancers - a Southwest Oncology Group study. Cancer Research, 54, 5357-5362.
15. Fatum, M., Gyo, Y., Diana, P., Laufer, N., & Simon, A. (2006). Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole). Journal of Assisted Reproduction and Genetics, 23, 407-412.
16. Goswami, S.K., Das, T., Chattopadhyay, R., Sawhney, V., Kumar, J., Chaudhury, K., Chakravarty, B.N., & Kabir, S.N. (2004). A randomized single-blind controlled trial of letrozole as a lowcost IVF protocol in women with poor ovarian response: a preliminary report. Human Reproduction, 19, 2031-2035.
17. Garcia-Velasco, J.A., Moreno, L., Pacheco, A., Guillén, A., Duque, L., Requena, A., & Pellicer, A. (2005). The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertility & Sterility, 84, 82-87.
18. Holzer, H., Casper, R., & Tulandi, T. (2006). A new era in ovulation induction. Fertility & Sterility, 85, 277-284.
19. Hu, Y., Cortvrindt, R., & Smitz, J. (2002). effects of aromatase inhibition on in vitro follicle and oocyte development analysed by early preantral mouse follicle culture. Molecular Reproduction and Development, 61, 549-559.
20. Jee, B.C., Ku, S.Y., Suh, C.S., Kim, K.C., Lee, W.D., & Kim, S.H. (2006). Use of Letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertility & Sterility, 85, 1774-1777.
21. Kafy, S. & Tulandi, T. (2007). New advances in ovulation induction. Current Opinion in Obstetrics and Gynecology, 19, 248-252.
22. Lu, Q., Yue, W., Wang, J., Liu, Y., Long, B., & Brodie, A. (1998). The effects of aromatase inhibitors and antiestrogens in the nude mouse model. Breast Cancer Research and Treatment, 50, 63-71.
23. Luthra, R., Kirma, N., Jones, J., & Tekmal, R.R. (2003). Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice. Journal of Steroid Biohemistry and Molecular Biology, 86, 461-467.
24. Mitwally, M.F. & Casper, R.F. (2001). Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertility & Sterility, 75, 305-309.
25. Mitwally, M.F., Biljan, M.M., & Casper RF. (2005). Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. American Journal of Obstetrics and Gynecology, 192, 381-386.
26. Mitwally, M.F. & Casper, R.F. (2005). Single- dose administration of an aromatase inhibitor for ovarian stimulation. Fertility & Sterility, 83, 229-231.
27. Oktay, K., Buyuk, E., Libertella, N., Akar, M., & Rosenwaks, Z. (2005). Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and Letrozole for embryo cryopreservation. Journal of Clinical Oncology, 23, 4347-4353.
28. Oktay, K., Hourvitz, A., Sahin, G., Oktem, O., Safro, B., Cil, A., & Bang, H. (2006). Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. Journal of Clinical Endocrinology and Metabolism, 91, 3885-3890.
29. Partridge, A.H. & Farber, D. (2008). Fertility preservation: A vital survivorship issue for young women with breast cancer. Journal of Clinical Oncology, 26, 2612-2613.
30. Paridaens, R., Heuson, J.C., Julien, J.P., Veyret, C., Van Zyl, J., Klijn, J.G., Sylvester, R., & Mignolet, F. (1993). Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. Journal of Clinical Oncology, 11, 1723-1728
31. Platet, N., Cathiard, A.M., Gleizes, M., & Garcia, M. (2004). Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Critical Reviews in Oncology/Hematology, 51, 55-67.
32. Requena, A., Herrero, J., Landeras, J., Navarro, E., Neyro, J.L., Salvador, C., Tur, R., Callejo, J., Checa, M.A., Farr é, M., Espinós, J.J., F ábregues, F., & Grañ a-Barcia, M; Reproductive Endocrinology Interest Group of Spanish Society of Fertility. (2008). Use of letrozole in assisted reproduction: a systematic review and meta analysis. Human Reproduction Update, 14, 571-582.
33. Schoolcraft, W.B., Surrey, E.S., Minjarez, D.A., Stevens, J.M., & Gardner, D.K. (2008). Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol? Fertility & Sterility, 89, 152-156.
34. Tulandi, T., Martin, J., Al-Fadhli R., Kabli, N., Forman, R., Hitkari, J., Librach, C., Greenblatt, E., & Casper, R.F. (2006). Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility & Sterility, 89, 1761-1765.
35. Verpoest WM, Kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem A, Devroey, P. (2006). Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reproductive Biomedicine Online, 13, 166-172.
36. Yue, W., Zhou, D., Chen S., & Brodie, A. (1994). A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Research, 54, 5092-5095.
37. Yue, W., Santen, R.J., Wang, J.P., Hamilton, C.J., & Demers, L.M. (1999). Aromatase within the breast. Endocrine-related Cancer, 6, 157-164.
38. Zeinalzadeh, M., Basirat, Z., & Esmailpour, M. (2010). Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome. Journal of Reproductive Medicine, 55, 36-40.